Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq

BACKGROUND: The pathogenic mechanism of dilated cardiomyopathy (DCM) remains to be defined. This study aimed to identify hub genes and immune cells that could serve as potential therapeutic targets for DCM. METHODS: We downloaded four datasets from the Gene Expression Omnibus (GEO) database: GSE1419...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chenggang, Lv, Zhan, Yu, Zhimin, Wang, Kexin, Xu, Chengkai, Li, Yixuan, Wang, Yanggan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290235/
https://www.ncbi.nlm.nih.gov/pubmed/35850644
http://dx.doi.org/10.1186/s12872-022-02759-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290235/
https://www.ncbi.nlm.nih.gov/pubmed/35850644
http://dx.doi.org/10.1186/s12872-022-02759-7

Ejemplares similares